Overview

Ataraxis is an AI precision-oncology platform that combines pathology images with clinical data to inform cancer prognosis and treatment decisions. Its models identify imaging biomarkers and predict patient outcomes and treatment response. The Ataraxis Breast suite covers recurrence risk, individualized chemotherapy benefit, and response to neoadjuvant therapy using existing pathology specimens.

Key features

Multimodal learning across pathology and clinical data
Kestrel pan-cancer digital pathology foundation model
Five-year breast cancer recurrence risk prediction
Individualized chemotherapy benefit estimates
Neoadjuvant therapy response prediction
Pathologic complete response prediction
Analysis using existing pathology specimens
Models designed for additional cancer indications

Use cases

Show all 6Show fewer

Chemotherapy benefit assessment

Alternatives

AbridgeAmbient AI platform that turns clinical conversations into reviewable, billable notes inside EHR workflows.ai agent
CareFlo AIHealthcare automation agents for referrals, eligibility, authorizations, documentation, scheduling, and revenue cycle workflows.ai agentPaid
Paratus HealthHealthcare voice AI that answers patient calls, schedules appointments, and automates routine front-office workflows.ai agent
Ambience HealthcareAmbient AI platform for clinical documentation, chart answers, care tasks, and medical coding.ai agent
G LNKHealthcare intelligence platform for searching clinicians, analyzing institutions, and planning life-sciences outreach.ai agentPaid
IntenseyeReal-time workplace safety platform that uses computer vision to detect hazards and trigger responses.ai agentPaid